Clinical Trial

Development of Clinically High Efficient Platforms for Individualised Treatment of Cervix Cancer

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 20, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
Retrospective study utilizing patient data to develop and validate Machine Learning application. Available imaging data sets of patients who have completed treatment will be used to develop Normal tissue complication probability and Tumour control probability Hypothesis Integrating existing radiation treatment information, quantitative imaging and patient outcome data from completed and ongoing clinical trials will allow development of knowledge based systems for efficient treatment delivery and allow selection of patients for intensified treatment approaches in cervix cancer.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2021-10-20; most recent amendment 2026-02-18.
Status change: Active, Not Recruiting → Recruiting 2026-02-18
Status change: Not Yet Recruiting → Active, Not Recruiting 2022-10-20
Trial Details
NCT Number NCT05102240
Lead Sponsor Tata Memorial Hospital
Collaborators: Bhabha Atomic Research Centre, Erasmus Medical Center
Conditions Cervix Cancer
Enrollment 1,800 participants
Start Date 2022-02-24
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-20